| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Nano Dimension Ltd.
13D/A
NNDM · 63008G203
|
10.1% |
10/29/2026
Event 10/22/2026
|
||||
| Murchinson Ltd. | 10.1% | |||||
| Nomis Bay Ltd. | 3.0% | |||||
| BPY Ltd. | 2.0% | |||||
| EOM Management Ltd. | 5.1% | |||||
| James Keyes | 5.1% | |||||
| Jason Jagessar | 5.1% | |||||
| Chaja Carlebach | 5.1% | |||||
| Clarendon Hugh Masters | 5.1% | |||||
| Marc J. Bistricer | 10.1% | |||||
| Schedule 13G · 2 securities · passive | ||||||
|
Valion Bio, Inc.
13G
VBIO · 888705308
|
10.0% |
7/17/2026
Event 6/8/2026
|
||||
| Murchinson Ltd. | 10.0% | |||||
| Marc Bistricer | 10.0% | |||||
| BPY Ltd. | 10.0% | |||||
| Nomis Bay Ltd. | 10.0% | |||||
| Nomis Bay Opportunity Ltd. | 10.0% | |||||
| EOM Management Ltd. | 10.0% | |||||
| James Keyes | 10.0% | |||||
| Jason Jagessar | 10.0% | |||||
| Chaja Carlebach | 10.0% | |||||
|
Pelthos Therapeutics Inc.
13G
PTHS · 171126204
|
9.1% |
11/14/2025
Event 9/30/2025
|
||||
| Murchinson Ltd. | 9.1% | |||||
| Marc Bistricer | 9.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.